Hypomania and mania related to dopamine replacement therapy in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue 4, 2014, Pages 421-427

  Maier, Franziska ^a   Merkl, Josuah ^a   Ellereit, Anna L ^a   Lewis, Catharine J ^a   Eggers, Carsten ^a   Pedrosa, David J ^a   Kalbe, Elke ^a,b   Kuhn, Jens ^a   Meyer, Thomas D ^c   Zurowski, Mateusz ^d   Timmermann, Lars ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF VECHTA   (Germany)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Dopamine dysregulation; Dopamine replacement therapy; Hypomania; Impulse control disorders; Mania; Parkinson's disease

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE; ROTIGOTINE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DELUSION; DEPRESSION; DOPAMINE REPLACEMENT THERAPY; DSM-IV; DYSKINESIA; FEMALE; GERMANY; HALLUCINATION; HUMAN; HYPOMANIA; HYPOMANIC PERSONALITY SCALE; MAJOR CLINICAL STUDY; MALE; MANIA; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; QUESTIONNAIRE; SELF REPORT MANIC INVENTORY; SUBSTITUTION THERAPY; AGED; BIPOLAR DISORDER; CHEMICALLY INDUCED; MIDDLE AGED; PREVALENCE; PSYCHOLOGY;

ADULT; AGED; BIPOLAR DISORDER; DOPAMINE AGONISTS; HUMANS; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE;

EID: 84897958418     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.01.001     Document Type: Article

References (28)

1. APA Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC. 4th ed.
2. Cummings J.L. Behavioral complications of drug treatment of Parkinson's disease. JAm Geriatr Soc 1991, 39:708-716.
3. Singh A., Althoff R., Martineau R.J., Jacobson J. Pramipexole, ropinirole, and mania in Parkinson's disease. Am J Psychiatry 2005, 162:814-815.
4. Giovannoni G., O'Sullivan J.D., Turner K., Manson A.J., Lees A.J. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. JNeurol Neurosurg Psychiatry 2000, 68:423-428.
5. Limotai N., Oyama G., Go C., Bernal O., Ong T., Moum S.J., et al. Addiction-like manifestations and Parkinson's disease: a large single center 9-year experience. Int J Neurosci 2012, 122:145-153.
6. Cilia R, Siri C, Canesi M, Zecchinelli AL, De Gaspari D, Natuzzi F, et al. Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome. J Neurol Neurosurg Psychiatry, published online 16 April 2013. http://dx.doi.org/10.1136/jnnp-2012-303988.
7. Voon V., Thomsen T., Miyasaki J.M., de Souza M., Shafro A., Fox S.H., et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 2007, 64:212-216.
8. Voon V., Fox S.H. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007, 64:1089-1096.
9. Weintraub D., Koester J., Potenza M.N., Siderowf A.D., Stacy M., Voon V., et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010, 67:589-595.
10. Voon V., Sohr M., Lang A.E., Potenza M.N., Siderowf A.D., Whetteckey J., et al. Impulse control disorders in Parkinson disease: a multicenter case-control study. Ann Neurol 2011, 69:986-996.
11. Evans A.H., Pavese N., Lawrence A.D., Tai Y.F., Appel S., Doder M., et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 2006, 59:852-858.
12. Weintraub D., Nirenberg M.J. Impulse control and related disorders in Parkinson's disease. Neurodegener Dis 2013, 11:63-71.
13. Ulla M., Thobois S., Llorca P.M., Derost P., Lemaire J.J., Chereau-Boudet I., et al. Contact dependent reproducible hypomania induced by deep brain stimulation in Parkinson's disease: clinical, anatomical and functional imaging study. JNeurol Neurosurg Psychiatry 2011, 82:607-614.
14. Chopra A., Tye S.J., Lee K.H., Sampson S., Matsumoto J., Adams A., et al. Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature. JNeuropsychiatry Clin Neurosci 2012, 24:102-110.
15. Hughes A.J., Daniel S.E., Blankson S., Lees A.J. Aclinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993, 50:140-148.
16. Kalbe E., Kessler J., Calabrese P., Smith R., Passmore A.P., Brand M., et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 2004, 19:136-143.
17. Fahn S., Elton R.L., Committee U.D. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, 153-163. MacMillan Healthcare Information, Floral Park, NY. S. Fahn, C.D. Marsden, D. Calne, M. Goldstein (Eds.).
18. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
19. Diener H.C., Putzki N. Leitlinien für Diagnostik und Therapie in der Neurologie 2008, Georg Thieme Verlag, Stuttgart. 4th ed.
20. Shugar G., Schertzer S., Toner B.B., Di Gasbarro I. Development, use, and factor analysis of a self-report inventory for mania. Compr Psychiatry 1992, 33:325-331.
21. Kruger S., Braunig P., Shugar G. Manie-selbstbeurteilungsskala (MSS). manual 1997, Beltz, Goettingen.
22. Eckblad M., Chapman L.J. Development and validation of a scale for hypomanic personality. JAbnorm Psychol 1986, 95:214-222.
23. Meyer T.D., Druke B., Hautzinger M. Hypomanic personality - psychometric evaluation and first results concerning the validity of the German version of the Chapman-scale. ZKlin Psychol Forsc 2000, 29:35-42.
24. Beck A.T., Steer R.A., Ball R., Ranieri W. Comparison of beck depression inventories-IA and -II in psychiatric outpatients. JPers Assess 1996, 67:588-597.
25. Lezak M.D., Howieson B.H., Loring D.W. Neuropsychological assessment 2004, Oxford University Press, New York.
26. Voon V., Saint-Cyr J., Lozano A.M., Moro E., Poon Y.Y., Lang A.E. Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery. JNeurosurg 2005, 103:246-251.
27. Kessler R.C., Berglund P.A., Demler O., Jin R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 2005, 62:593-602.
28. Judd L.L., Akiskal H.S. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. JAffect Disord 2003, 73:123-131.